Evid Invest
Who owns ORICWhat ORIC owns — n/a

Who owns Oric Pharmaceuticals, Inc.?

Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.

Institutional ownership of ORIC from SEC Form 13F filings across 203 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.

As of the 2026-09-30 reporting period, 203 institutions disclosed 118.6M shares of Oric Pharmaceuticals, Inc. worth $1.59B — about 109.6% of shares outstanding; the largest disclosed holder is Nextech Invest Ltd.. Source: SEC Form 13F filings, parsed by EvidInvest.

203

13F holders

$1.59B

value, 2026 filers

109.6%

of shares outstanding (118.6M sh)

44

new positions (2026 filers)

Top institutional holders

ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of ORIC's shares outstanding

#ManagerSharesValue% of fund% of co.Δ shares QoQ
1Nextech Invest Ltd.7.2M$96.5M4.3%6.6%0.0%
2BlackRock, Inc.7.0M$94.0M0.0%6.5%+2.3%
3PRICE T ROWE ASSOCIATES INC /MD/5.1M$68.5M0.0%4.7%-23.1%
4AIHC Capital Management Ltd4.6M$62.4M57.4%4.3%+21.0%
5SR ONE CAPITAL MANAGEMENT, LP4.6M$62.2M5.4%4.3%0.0%
6STATE STREET CORP4.1M$55.6M0.0%3.8%-15.7%
7NEA Management Company, LLC4.1M$55.5M4.1%3.8%0.0%
8VANGUARD CAPITAL MANAGEMENT LLC4.1M$54.9M0.0%3.8%+3.1%
9VIKING GLOBAL INVESTORS LP3.6M$48.0M0.1%3.3%-30.5%
10Column Group LLC3.5M$47.7M38.4%3.3%0.0%
11Siren, L.L.C.3.4M$45.2M1.1%3.1%+12.0%
12ALKEON CAPITAL MANAGEMENT LLC3.2M$43.6M0.1%3%-13.4%
13EcoR1 Capital, LLC3.0M$40.8M1.8%2.8%-55.0%
14Venrock Adviser, LLC2.9M$39.7M1.9%2.7%-31.8%
15FMR LLC2.6M$35.5M0.0%2.4%-0.1%
16D. E. Shaw & Co., Inc.2.5M$33.1M0.0%2.3%+55.3%
17Defilade Capital Management, L.P.2.3M$30.6M5.1%2.1%+116.9%
18GEODE CAPITAL MANAGEMENT, LLC2.2M$29.6M0.0%2%+5.0%
19CITADEL ADVISORS LLC2.1M$28.4M0.0%2%-18.6%
20MORGAN STANLEY2.0M$27.4M0.0%1.9%+13.5%
21DIMENSIONAL FUND ADVISORS LP1.9M$25.6M0.0%1.8%+5.5%
22FRANKLIN TEMPLETON INC1.9M$17.6M0.0%1.7%+4.9%
23MPM BIOIMPACT LLC1.8M$24.5M1.8%1.7%-3.2%
24GOLDMAN SACHS GROUP INC1.8M$24.3M0.0%1.7%-26.5%
25Integral Health Asset Management, LLC1.7M$20.2M1.2%1.6%-10.5%

Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.